High survivin expression as a predictor of poor response to preoperative chemoradiotherapy in locally advanced rectal cancer

International Journal of Colorectal Disease

Volumn 26, Issue 8, 2011, Pages 1019-1023

  Kim, Kyubo ^a   Chie, Eui Kyu ^a   Wu, Hong Gyun ^a   Kim, Sang Gyun ^a   Lee, Seung Hee ^a   Kang, Gyeong Hoon ^a   Hyun, Chang Lim ^a   Ha, Sung W ^a  

^a Seoul National University   (South Korea)

Author keywords

Molecular marker; Preoperative chemoradiotherapy; Rectal cancer; Survivin

Indexed keywords

CAPECITABINE; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; KI 67 ANTIGEN; PROTEIN P21; SURVIVIN; THYMIDYLATE SYNTHASE; VASCULOTROPIN;

ADVANCED CANCER; ARTICLE; CANCER REGRESSION; CANCER STAGING; CHEMORADIOTHERAPY; CONTROLLED STUDY; DRUG RESPONSE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION RESPONSE; RECTUM BIOPSY; RECTUM CARCINOMA; RECTUM RESECTION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; RECTAL NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 80051590837     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-011-1180-1     Document Type: Article

References (15)

1. LA Kachnic 2006 Should preoperative or postoperative therapy be administered in the management of rectal cancer? Semin Oncol 33 suppl 11 s64 s69 17178291 10.1053/j.seminoncol.2006.10.018 1:CAS:528:DC%2BD2sXhsVSnurk%3D (Pubitemid 44908580)
2. R Sauer H Becker W Hohenberger, et al. 2004 Preoperative versus postoperative chemoradiotheraepy for rectal cancer N Engl J Med 351 1731 1740 15496622 10.1056/NEJMoa040694 1:CAS:528:DC%2BD2cXovFSksbo%3D (Pubitemid 39383208)
3. JG Kuremsky JE Tepper HL McLeod 2009 Biomarkers for response to neoadjuvant chemoradiation for rectal cancer Int J Radiat Oncol Biol Phys 74 673 688 19480968 10.1016/j.ijrobp.2009.03.003 1:CAS:528:DC%2BD1MXmsFyiu7g%3D
4. O Dworak L Keilholz A Hoffmann 1997 Pathological features of rectal cancer after preoperative radiochemotherapy Int J Colorectal Dis 12 19 23 9112145 10.1007/s003840050072 1:STN:280:DyaK2s3ms1emsw%3D%3D (Pubitemid 27138353)
5. H Kawasaki DC Altieri CD Lu, et al. 1998 Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer Cancer Res 58 5071 5074 9823313 1:CAS:528:DyaK1cXnsFSmt78%3D (Pubitemid 28521163)
6. AI Sarela N Scott J Ramsdale, et al. 2001 Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas Ann Surg Oncol 8 305 310 11352303 10.1007/s10434-001-0305-0 1:STN:280:DC%2BD3M3lsVWgug%3D%3D (Pubitemid 32422855)
7. F Rödel J Hoffmann GG Grabenbauer, et al. 2002 High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection Strahlenther Onkol 178 426 435 12240548 10.1007/s00066-002-1003-y (Pubitemid 34847422)
8. F Rödel J Hoffmann L Distel, et al. 2005 Survivin as a radioresistence factor, and prognostic and therapeutic target for radiotherapy in rectal cancer Cancer Res 65 4881 4887 15930309 10.1158/0008-5472.CAN-04-3028 (Pubitemid 40740827)
9. F Rödel B Frey W Leitmann, et al. 2008 Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models Int J Radiat Oncol Biol Phys 71 247 255 18406888 10.1016/j.ijrobp.2008.02.011 (Pubitemid 351491424)
10. A Knutsen G Adell XF Sun 2004 Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy Int J Radiat Oncol Biol Phys 60 149 155 15337550 10.1016/j.ijrobp.2004.02.007 1:CAS:528:DC%2BD2cXntFSlsbg%3D (Pubitemid 39165479)
11. DT McDowell FM Smith JV Reynolds, et al. 2009 Increased spontaneous apoptosis, but not survivin expression, is associated with histomorphologic response to neoadjuvant chemoradiation in rectal cancer Int J Colorectal Dis 24 1261 1269 19593573 10.1007/s00384-009-0755-6
12. C Terzi AE Canda O Sagol, et al. 2008 Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy Int J Colorectal Dis 23 37 45 17805549 10.1007/s00384-007-0376-x (Pubitemid 350142358)
13. J Giralt M de las Heras L Cerezo, et al. 2005 The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis Radiother Oncol 74 101 108 15816107 10.1016/j.radonc.2004.12.021 1:CAS:528:DC%2BD2MXhslWnsrc%3D (Pubitemid 40331866)
14. JS Kim JM Kim S Li, et al. 2006 Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy Int J Radiat Oncol Biol Phys 66 195 200 16839708 10.1016/j.ijrobp.2006.04.026 (Pubitemid 44175651)
15. I Zlobec T Vuong CC Compton, et al. 2008 Combined analysis of VGEF and EGFR predicts complete tumor response in rectal cancer treated with preoperative radiotherapy Br J Cancer 98 450 456 18182986 10.1038/sj.bjc.6604172 1:CAS:528:DC%2BD1cXhtVGqtr8%3D (Pubitemid 351161259)